O'Shaughnessy Asset Management, LLC Neurocrine Biosciences Inc Transaction History

O'Shaughnessy Asset Management, LLC

$14.2 Billion
Q2 2025

A detailed history of O'Shaughnessy Asset Management, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, O'Shaughnessy Asset Management, LLC holds 4,829 shares of NBIX stock, worth $671,617. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,829

Previous 3,230 49.5%

Holding current value

$671,617

Previous $357,000 69.75%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$87.54 - $128.18 $139,976 - $204,959	1,599 Added 49.5%	4,829 $606,000
Q1 2025 May 13, 2025	SELL	$107.22 - $153.29 $58,220 - $83,236	-543 Reduced 14.39%	3,230 $357,000
Q4 2024 Feb 12, 2025	SELL	$111.62 - $139.44 $4,018 - $5,019	-36 Reduced 0.95%	3,773 $515,000
Q3 2024 Nov 12, 2024	SELL	$114.58 - $153.15 $52,821 - $70,602	-461 Reduced 10.8%	3,809 $438,000
Q2 2024 Aug 14, 2024	BUY	$130.86 - $143.19 $75,244 - $82,334	575 Added 15.56%	4,270 $587,000
Q1 2024 May 13, 2024	BUY	$130.4 - $143.74 $69,242 - $76,325	531 Added 16.78%	3,695 $509,000
Q4 2023 Feb 09, 2024	BUY	$106.07 - $132.76 $11,561 - $14,470	109 Added 3.57%	3,164 $416,000
Q3 2023 Nov 13, 2023	BUY	$94.02 - $117.1 $287,231 - $357,740	3,055 New	3,055 $343,000
Q1 2023 May 12, 2023	SELL	$94.11 - $123.02 $51,101 - $66,799	-543 Reduced 18.67%	2,366 $239,000
Q4 2022 Feb 10, 2023	BUY	$106.72 - $127.06 $38,952 - $46,376	365 Added 14.35%	2,909 $347,000
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $234,124 - $274,268	2,544 New	2,544 $270,000
Q4 2021 Feb 11, 2022	SELL	$79.65 - $106.22 $97,491 - $130,013	-1,224 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$86.18 - $99.03 $92,815 - $106,655	-1,077 Reduced 46.81%	1,224 $118,000
Q2 2021 Aug 09, 2021	BUY	$89.43 - $102.27 $3,308 - $3,783	37 Added 1.63%	2,301 $224,000
Q1 2021 May 14, 2021	SELL	$87.57 - $119.4 $22,680 - $30,924	-259 Reduced 10.27%	2,264 $220,000
Q4 2020 Feb 11, 2021	BUY	$86.91 - $108.33 $64,139 - $79,947	738 Added 41.34%	2,523 $242,000
Q3 2020 Nov 12, 2020	BUY	$96.16 - $135.15 $54,811 - $77,035	570 Added 46.91%	1,785 $172,000
Q2 2020 Aug 13, 2020	BUY	$85.09 - $130.36 $103,384 - $158,387	1,215 New	1,215 $148,000
Q1 2020 May 13, 2020	SELL	$75.11 - $113.76 $1,727 - $2,616	-23 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$86.8 - $118.57 $1,996 - $2,727	23 New	23 $2,000

Others Institutions Holding NBIX

# of Institutions

656

Shares Held

101M

Call Options Held

290K

Put Options Held

214K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.3B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.

Account

O'Shaughnessy Asset Management, LLC Neurocrine Biosciences Inc Transaction History